A Single-Arm Evaluation of the Safety of Paliperidone Extended-Release (ER) in Subjects With Schizophrenia or Schizoaffective Disorder With Hepatic Disease.
Phase of Trial: Phase IV
Latest Information Update: 19 Sep 2013
At a glance
- Drugs Paliperidone (Primary) ; Antipsychotics
- Indications Schizoaffective disorder; Schizophrenia
- Focus Adverse reactions; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 10 Jun 2009 Planned number of patients changed from 100 to 121 Actual end date (Mar 2007) added as reported by ClinicalTrials.gov.
- 10 Jun 2009 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.